aTYR PHARMA INC Accounts Payable
aTYR PHARMA INC (ATYR) had Accounts Payable of $3.24 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Payable, Current $3.24M.
- 2026-03-31: Accounts Payable, Current $2.75M.
- 2025-12-31: Accounts Payable, Current $3.89M.
- 2025-09-30: Accounts Payable, Current $4.06M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $3.24M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $2.75M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $3.89M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $4.06M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $3.88M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.53M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $4.32M 10-K · filed 2026-03-05 |
| 2024-09-30 | $3.95M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.25M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $4.89M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $3.53M 10-K · filed 2025-03-13 |
| 2023-09-30 | $2.04M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $516.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.96M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.11M 10-K · filed 2024-03-14 |
| 2022-09-30 | $3.13M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.67M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.56M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.03M 10-K · filed 2023-03-14 |
| 2021-09-30 | $900.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $2.22M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $1.16M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.43M 10-K · filed 2022-03-15 |
| 2020-09-30 | $1.35M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $603.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $748.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $847.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $1.32M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $664.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $834.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $1.04M 10-K · filed 2020-03-26 |
| 2018-09-30 | $599.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $832.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.46M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $2.28M 10-K · filed 2019-03-26 |
| 2017-09-30 | $3.59M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $2.67M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.25M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $2.61M 10-K · filed 2018-03-20 |
| 2016-09-30 | $3.56M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $4.72M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $5.88M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $3.87M 10-K · filed 2017-03-16 |
| 2015-09-30 | $1.59M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $3.00M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $3.17M 10-Q · filed 2015-06-18 |
| 2014-12-31 | $1.43M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |